Abstract
O-Cyclopropyl hydroxylamines, now accessible via a novel and scalable synthetic route, have been demonstrated to be bench-stable and practical precursors for the synthesis of N-heterocycles via a di-heteroatom [3,3]-sigmatropic rearrangement. In order to study the reactivity of these compounds in depth, a robust synthesis of both ring-substituted and ring-unsubstituted O-cyclopropyl hydroxylamines has been developed. Metal-free conditions for the facile N-arylation of these precursors were also identified. It was found that the N-Arylated O-cyclopropyl hydroxamates can efficiently undergo a one-pot [3,3]-sigmatropic rearrangement/cyclization/rearomatization cascade under base-mediated conditions to furnish a structurally diverse set of substituted tetrahydroquinolines.
Graphical Abstract
A novel and scalable synthesis of O-cyclopropyl hydroxylamines is reported. These compounds are bench-stable and have been shown to be practical precursors for the synthesis of N-heterocycles via a di-heteroatom [3,3]-sigmatropic rearrangement.
Introduction
[3,3]-Sigmatropic rearrangements are highly valuable transformations en route to both carbo- and heterocycles due to their overall synthetic efficiency and atom economy. For the preparation of oxygen- and nitrogen-containing heterocycles, [3,3]-rearrangements that involve cleavage of weak N-O bonds are of particular interest. The acid-catalyzed [3,3]-rearrangement of aryloxime ethers to form benzofurans is an excellent example of O-heterocycle formation (Scheme 1A).[1] This reaction mechanism is comparable to that of the Fischer-indole synthesis, in which the key [3,3]-rearrangement involves cleavage of the weak N-N bond in N-arylhydrazone substrates. Another noteworthy N-heterocycle-forming reaction is the Bartoli indole synthesis, which involves the [3,3]-rearrangement of an in situ-generated N-aryl-O-vinylhydroxylamine intermediate via N-O bond cleavage (Scheme 1B).[2] These types of cascade reactions have been shown to be robust methods to produce substituted heterocycles.
Scheme 1.
[3,3]-Sigmatropic Rearrangements that Involve N-O bonds and Lead to the Formation of C-O and C-N Bonds.
Inspired by the N-aryl-O-vinylhydroxylamine intermediate (7, Scheme 1B) that is involved in the Bartoli indole synthesis, we proposed that O-cyclopropyl hydroxylamine, an analogous and potentially bench-stable compound, could serve as a [3,3]-sigmatropic rearrangement precursor to furnish a variety of substituted heterocycles. It is likely that O-cyclopropyl hydroxylamines can be further derivatized, which would make them homologues of the highly reactive and transient precursors for [3,3]-rearrangements that involve N-O bond cleavage. O-Cyclopropyl hydroxylamine is hypothesized to possess similar reactivity to the O-vinyl hydroxylamine intermediates shown in the heterocycle-forming reactions above in Schemes 1A & 1B, because it features both a readily cleavable N-O bond[3] and a strained cyclopropane C-C bond (i.e., banana bond) that ultimately could serve as a three-carbon homoenolate equivalent (Scheme 1C).[4] Therefore, these two reactive sites have the potential to participate in a homologous [3,3]-sigmatropic rearrangement when a π-system (i.e., vinyl or aryl group) is directly attached to the nitrogen atom.[5]
As an initial proof of concept, we proposed that N-protected/N-arylated derivatives of O-cyclopropyl hydroxylamine (12, Scheme 1D) should undergo a [3,3]-rearrangement to furnish 2-hydroxy-tetrahydroquinolines (14). If these types of compounds efficiently undergo [3,3]-rearrangement, it can be envisioned that other O-cyclopropyl hydroxylamine derivatives such as N-vinyl or N-acyl derivatives could be synthesized and would in turn undergo [3,3]-rearrangement to afford a variety of other heterocycles.
Herein we report a gram-scale synthesis for O-cyclopropyl hydroxylamines as well as a protocol for the facile N-arylation of these compounds. Additionally, we disclose the synthesis of twenty α-functionalized tetrahydroquinolines from O-cyclopropyl N-aryl hydroxamate substrates, demonstrating that these compounds can in fact function as suitable [3,3]-rearrangement precursors.
Results and Discussion
Initially, we set out to synthesize the target O-cyclopropyl hydroxylamine compound (10) via direct O-cyclopropanation of N-Boc hydroxylamine. Unfortunately, neither O-alkylation with bromocyclopropane/strong base nor transition metal-catalyzed cross-coupling with cyclopropyl boronic acid were successful in our hands.[6] Subsequently, a novel approach where the cyclopropane ring could be installed via olefin cyclopropanation was identified as an alternate synthetic route.[7]
We proposed that 2-(vinyloxy)isoindoline-1,3-dione (15a)[5d, 8] could function as an ideal cyclopropanation substrate because it contains the desired N-O-vinyl connectivity. After several optimizations, it was found that efficient cyclopropanation of 15a was possible under Simmons-Smith-type conditions with trifluoracetic acid used as an additive (Scheme 2).[9] The product, 2-cyclopropoxyisoindoline-1,3-dione (16a), was then subjected to standard hydrazine hydrate-mediated phthalimide-cleavage conditions,[10] followed by hydrochloride salt-formation. Utilizing this three-step approach, over eight grams of the desired O-cyclopropyl hydroxylamine was prepared and fully characterized as the hydrochloride salt 17a. It is noteworthy that the free-base form of O-cyclopropyl hydroxylamine 10 was volitile under vacuum.
Scheme 2.
Gram-scale synthesis of O-cyclopropyl hydroxylamine hydrochloride salt.
In addition to the synthesis of ring-unsubstituted 2-cyclopropoxyisoindoline-1,3-dione (16a), six ring-substituted derivatives 16b-g were also synthesized in high yields (Scheme 3). Substituted 2-(vinyloxy)isoindoline-1,3-diones with an aliphatic or aromatic substituent in either the α− or β− position (15b-e) were successfully converted to their corresponding cyclopropoxy products 16a-e under these conditions. Di-substituted olefins also efficiently underwent cyclopropanation to form 16f and 16g. From these examples, 16b was subjected to the phthalimide-cleavage conditions to produce ring-substituted O-cyclopropyl hydroxylamine 17b (Scheme 4) in 78% isolated yield. Unlike O-cyclopropyl hydroxylamine 10, the free-base form of the ring-substituted O-cyclopropyl hydroxylamine 17b was non-volatile under reduced pressure. Both HCl salt 17a and free-base 17b were bench-stable compounds and could be stored in a −20 °C freezer for several months. Even after long-term storage, no significant amounts of decomposition were observed, and these compounds were successfully carried through further functionalization steps.
Scheme 3.
Ring-unsubstituted and ring-substituted O-cyclopropyl N-hydroxyphthalimide products.
[a] 11.33 mmol scale. [b] 5.0 mmol scale. [c] 6 hours reaction time.
Scheme 4.
N-Protection of O-cyclopropyl hydroxylamines.
Ring-unsubstituted and ring-substituted O-cyclopropyl hydroxylamines (17a and 17b) were then converted to the corresponding tert-butyl, methyl, ethyl and benzyl cyclopropoxy-carbamates (18a-e, Scheme 4).
With the synthesis of O-cyclopropyl hydroxamates now optimized, the next step was to identify suitable N-arylation conditions for these substrates. In our hands, established N-arylation methods such as Buchwald-Hartwig or Chan-Lam cross-couplings[11] failed, which prompted us to explore metal- free (i.e., diaryliodonium salt-mediated) N-arylation conditions.[12] Through optimization studies (Table 1), it was found that the triflate diphenyliodonum salt yielded the largest amount arylated product compared to other salts (Entries 1–4, Table 1). When the amount of Ph2IOTf was decreased from 1.5 to 1.2 equivalents the yield was nearly quartered (75%→22%, [Entry 4 vs Entry 5, Table 1]). Increasing the equivalents of diphenyliodonium salt to 2.0, and conducting a reaction (1.5 equiv. of Ph2IOTf) at elevated temperatures also resulted in lower yields of the arylated product (Entry 8 and Entry 6, Table 1). However, it was observed that when a reaction with 1.5 equivalents of diphenyliodonium salt was stirred for an additional 3 hours, the yield could be further improved (6 h→9 h, 75%→82%, [Entry 4 vs Entry 7, Table 1]). The testing of different inorganic bases (Entries 9–12, Table 1) revealed that, Cs2CO3 was the ideal base for this transformation and could produce the highest yield of arylated product with the shortest reaction time. Solvents other than toluene were tested, but the use of dimethylformamide (DMF) and acetonitrile (CH3CN) resulted in low yields of the desired N-arylated product and observable yields of the 2-hydroxy-tetrahydroquinoline [3,3]-rearrangement product (Table 1, Entries 13 & 14). The optimal N-arylation conditions were found to be 1.5 equivalents of diaryliodonium triflate salt and 2.0 equivalents of Cs2CO3 in toluene (0.1 M in O-cyclopropyl hydroxamate) at room temperature.
Table 1.
Reaction optimization for N-arylation of O-cyclopropyl hydroxamates.
![]() | ||||||
---|---|---|---|---|---|---|
Entry[a] | Ph2IX (equiv.) | Base (2.0 equiv.) | Solvent (0.1 M) | Temp (°C) | Time (h) | 19a[b] (%) |
1 | BF4 (1.5) | Cs2CO3 | toluene | 25 | 12 | 20 |
2 | OTs (1.5) | Cs2CO3 | toluene | 25 | 12 | 29 |
3 | OMs (1.5) | Cs2CO3 | toluene | 25 | 12 | < 5 |
4 | OTf (1.5) | Cs2CO3 | toluene | 25 | 6 | 75 |
5 | OTf (1.2) | Cs2CO3 | toluene | 25 | 6 | 22 |
6 | OTf (1.5) | Cs2CO3 | toluene | 50 | 6 | 52 |
7 | OTf (1.5) | Cs2CO3 | toluene | 25 | 9 | 82 |
8 | OTf (2.0) | Cs2CO3 | toluene | 25 | 6 | 56 |
9 | OTf (2.0) | K2CO3 | toluene | 25 | 12 | 14 |
10[c] | OTf (2.0) | Na2CO3 | toluene | 25 | 12 | 0 |
11 | OTf (2.0) | KOt-Bu | toluene | 25 | 12 | 53 |
12 | OTf (2.0) | NaH | toluene | 25 | 12 | 19 |
13[d] | OTf (2.0) | Cs2CO3 | DMF | 25 | 12 | < 5 |
14[d] | OTf (2.0) | Cs2CO3 | CH3CN | 25 | 12 | 33 |
The reactions were performed on 0.2 mmol scale with a 0.1 M concentration of the N-protected O-cyclopropyl hydroxamate and stirred for the indicated amount of time.
NMR yields by analysis of 1H NMR of crude reaction mixtures with CH2Br2 as an internal standard.
89% of O-cyclopropyl hydroxamate starting material observed.
tert-butyl 2-hydroxy-3,4-dihydroquinoline-1(2H)-carboxylate (rearranged product) observed in crude 1H NMR (< 10%).
With the optimized N-arylation conditions in hand, the scope of substrates was explored using a variety of diaryliodonium salts. With Ph2IOTf, the ring-unsubstituted tert-butyl, methyl, ethyl and benzyl O-cyclopropyl hydroxamates (18a-d) furnished comparable yields of their corresponding arylated products (19a-d, Scheme 5). A diverse set of electron-withdrawing groups (i.e. nitriles, trifluoromethyl groups, ketones, esters and nitro groups) were tolerated on the aryl ring to furnish a total of nineteen (19) N-arylated products (19a-s, Scheme 5). The presence of an electron-donating group (i.e. methyl) on the aromatic ring allowed the hydroxamate substrate to undergo the N-arylation/[3,3]-sigmatropic rearrangement cascade in one-pot. Therefore, when p-tolyl-and m-tolyliodonium salts were used, the N-arylated intermediates were not isolated, but were subsequently subjected to rearrangement conditions to ensure their complete conversion to the corresponding heterocyclic products 20q-10t (Scheme 6). In our hands, when electron-rich diaryliodonium salts (e.g. p-methoxybenzeneiodonium salt) were utilized, significant decomposition occurred and only trace amounts of the desired N-arylated product could be observed. This result is consistent with other reported metal-free arylation conditions which demonstrate that the use of electron-rich diaryliodonium salts affords lower yields of the corresponding arylated products.[13] All of the N-arylated products were synthesized from symmetrical diaryliodonium salts, except for 19q and 19r. These examples were prepared by using the unsymmetrical diaryliodonium salt Ph(p-nitro-Ph)IOTf. The analysis of these examples allowed us to identify a clear reactivity trend: with the use of an unsymmetrical diaryliodonium salt the major product was formed as a result of the more electron-deficient aryl group being transferred, which is in alignment with previously reported findings.[14]
Scheme 5.
N-arylation of O-cyclopropyl hydroxamates.
[a] from Ph(p-nitro-Ph)IOTf.
Scheme 6.
2-hydroxy-tetrahydroquinoline products obtained via [3,3]-sigmatropic rearrangement.
[a] 60 °C, over 7 hours. [b] 80 °C, over 7 hours. [c] Isolated from one reaction of meta-substituted substrate. [d] From crude arylation reaction mixture that was directly subjected to rearrangement conditions.
To demonstrate the utility of O-cyclopropyl hydroxylamines as sigmatropic rearrangement precursors, optimal conditions for the [3,3]-rearrangement of N-arylated O-cyclopropyl hydroxamates to the corresponding 2-hydroxy-tetrahydroquinolines were identified (Table 2). Stirring the N-arylated starting material (19o) at ambient temperature without additives did not trigger the rearrangement (Entries 1 & 2, Table 2). Additionally, when Lewis acidic additives such as TfOH and ZnCl2 were used, formation of the desired product was not observed. It was found that with the addition of a base [i.e. triethylamine (Et3N)], the desired 2-hydroxy-tetrahydroquinoline (20o) was formed in THF, but not in toluene (Entries 3 & 4, Table 2). Screening of multiple solvents (Entries 5–8, Table 2) revealed trifluoroethanol (TFE) to be the ideal solvent for this transformation. Despite the fact that other basic additives were capable of producing the 2-hydroxy-tetrahydroquinoline product, none were as efficient as Et3N (Entries 10 &11, Table 2).
Table 2.
Reaction optimization for [3,3]-sigmatropic rearrangement of N-arylated O-cyclopropyl hydroxamates.
![]() | ||||
---|---|---|---|---|
Entry[a] | Additive (2.0 equiv.) | Solvent (0.1 M) | Time (h) | 20o[b] (%) |
1 | None | toluene | 48 | 0 |
2 | None | THF | 48 | 0 |
3 | Et3N | toluene | 48 | 0 |
4 | Et3N | THF | 48 | 22 |
5 | Et3N | DCM | 48 | 33 |
6 | Et3N | MeCN | 48 | 26 |
7 | Et3N | EtOH | 48 | 51 |
8 | Et3N | TFE | 26 | 66 |
9[c] | Et3N | TFE | 3 | 54 |
10 | DIPEA | TFE | 34 | 62 |
11 | Cs2CO3 | TFE | 30 | 59 |
Reactions performed on 0.1 mmol scale with a 0.1 M concentration of the N-arylated O-cyclopropyl hydroxamate. Stirred for the indicated amount of time at room temperature unless otherwise stated.
Isolated yields after column chromatography.
Reaction performed at 60 °C.
With the optimal conditions identified, the next step was to demonstrate the robustness of this [3,3]-sigmatropic rearrangement by exploring its scope of substrates. In this study, twenty (20) 2-hydroxy-tetrahydroquinoline products (20a-20p, Scheme 6) were successfully synthesized in moderate to good yields. The set of N-phenyl O-cyclopropyl hydroxamates 19a-d, which each possessed a different N-protecting group, efficiently underwent rearrangement producing their respective tetrahydroquinoline product in comparable yields (20a-d). A variety of functional groups on the aryl ring were tolerated and twelve (12) of the substituted N-aryl O-cyclopropyl hydroxamates synthesized in the previous transformation (19e-p) were successfully rearranged to the corresponding N-heterocycles (20e-20t). It was observed that substrates with more electron-deficient aromatic rings took longer to undergo the rearrangement/cyclization cascade compared to the less electron-deficient substrates. As previously stated, the N-arylated O-cyclopropyl hydroxamate examples with a methyl substituent on the aryl ring were not isolated but were successfully carried through the rearrangement conditions to produce tetrahydroquinoline products 20q-t in moderate yields. Interestingly, the m-tolyl Boc-protected substrate rearranged into a mixture of isolable regioisomers 20q and 20r. However, rearrangement of the m-tolyl Cbz-protected substrate produced only one regioisomer (20t). We hypothesize that this regioselectivity could be due to π-stacking interactions between the Cbz group and the N-aryl group prior to the [3,3]-rearrangement.
Additionally, it was demonstrated that the hydroxy-tetrahydroquinoline products could be further functionalized at their 2-position via straightforward C-C and C-O bond-forming transformations (Scheme 7).[6a, 15] Tetrahydroquinoline 20a was converted to an aliphatic or aromatic ether (21 or 22) under acidic condensation conditions or via a Chan-Lam-type coupling. Under Hosomi-Sakurai-type allylation conditions 20a was transformed into 2-allyl free amine 23. Finally, an in situ-generated phosphonium ylide from methyl 2-(diethoxyphosphoryl)acetate, was reacted with tetrahydroquinoline 20a to form 2-methoxy-2-oxoethyl addition product 24.
Scheme 7.
Further functionalization of 2-hydroxy-tetrahydroquinoline product 20a.
The [3,3]-rearrangement of ring-substituted N-aryl O-cyclopropyl hydroxamate substrate 19s has so far been suboptimal under the reaction conditions detailed above. Therefore, further refinement of the reaction conditions is required to achieve the facile and efficient [3,3]-rearrangement of the cyclopropyl ring-substituted substrates.
Conclusions
A scalable method for the direct synthesis of previously reported but uncharacterized ring-unsubstituted O-cyclopropyl hydroxylamine and previously unreported ring-substituted O-cyclopropyl hydroxylamines has been developed. These precursors were successfully N-protected/N-arylated and the resulting N-aryl O-cyclopropyl hydroxamate products were obtained in good to moderate yields. It was demonstrated that these hydroxamates could undergo a facile [3,3]-sigmatropic rearrangement followed by cyclization/rearomatization to efficiently produce the corresponding 2-hydroxy tetrahydroquinolines in a one-pot, three-step cascade reaction. Our studies clearly established the synthetic utility of bench-stable O-cyclopropyl hydroxylamines as precursors for the preparation of substituted N-heterocycles. Further exploitation of these valuable O-cyclopropyl hydroxylamine building blocks is currently underway in our laboratory.
Experimental Section
General Information
All starting material syntheses were performed in oven-dried 50 mL or 100 mL round-bottomed flasks. Commercially available solvents and reagents were used without further purification. All arylation reactions were carried out in oven-dried 8 mL scintillation vials, while rearrangement reactions were carried out in oven-dried 20 mL scintillation vials. All reactions were monitored by thin-layer chromatography (TLC) with E. Merck silica gel 60 F254 pre-coated plates (0.25 mm). Flash chromatography was carried out using a Biotage Isolera One system with 10g KP-Sil cartridges utilizing ethyl acetate (EA) and hexane (hex) as eluents. 1H and 13C nuclear magnetic resonance (NMR) spectra were obtained using a Bruker DRX-600 NMR spectrometer. Chemical shifts are documented in parts per million (δ, ppm). 1H NMR spectra are referenced to 7.26 (CDCl3) and 13C NMR spectra are referenced to 77.16 (CDCl3). High Resolution Mass Spectrometry was performed on an Agilent 1290/6230 LCMS-TOF under electrospray ionization (ESI) conditions in both positive and negative mode. Melting points were recorded on a Mettler Toledo MP50 melting point system.
The preparation of the N-enoxyphthalimides was carried out following literature reported protocols. N-enoxyphthalimide 15a was synthesized following protocol A[8] and the N-enoxyphthalimides (15b-g) were synthesized following copper promoted protocol B.[5d] The 1H and 13C NMR spectra of the obtained N-enoxyphthalimides were consistent with those reported in the literature.[8, 5d, 16]
General Procedure for the Preparation of 2-cyclopropoxyisoindoline-1,3-diones
Neat diethylzinc (20.5 mL, 200 mmol, 2.0 equiv.) was added to 250 mL of dry DCM under inert atmosphere in a glove box. The diethylzinc solution was removed from the glove box and kept under inert gas. A solution of trifluoroacetic acid (15.3 mL, 200 mmol, 2.0 equiv.) in DCM (125 mL) was slowly added to the diethylzinc solution at 0 °C and stirred until gas evolution ceased. After stirring at 0 °C for about 20 minutes, a solution of diiodomethane (16.13 mL, 200 mmol, 2.0 equiv.) in DCM (125 mL) was added. The mixture was stirred for an additional 20 minutes. Upon further stirring, a solution of N-enoxyphthalimide 15a (22.7 g, 120 mmol, 1.0 equiv.) in DCM (100 mL) was added. Then the reaction was removed from the ice bath, allowed to warm to rt and stirred for 2 h or until the reaction was complete by TLC analysis. Once the starting material was consumed, the reaction mixture was decanted into a separatory funnel and carefully quenched with 0.1 N HCl (500 mL). The organic layer was separated and washed with saturated NaHCO3, and brine. The organic layer was dried over Na2SO4, filtered and concentrated. The crude mixture was purified via flash chromatography (30% EA in hexanes) to give 2-cyclopropoxyisoindoline-1,3-dione 16a as a white solid. The same procedure was used to synthesize 16b-g from the corresponding N-enoxyphthalimides.
General Procedure for the Preparation of O-cyclopropyl Hydroxylamines
Hydrazine hydrate (50–60 %, 7.5 ml, 118 mmol, 2.8 equiv.) was added dropwise (over 3 minutes) to a solution of 2-cyclopropoxyisoindoline-1,3-dione 16a (8.5 g, 42 mmol, 1.0 equiv.) in diethyl ether (167 ml, 0.25 M) at 0 °C. The reaction mixture was allowed to warm to rt and stirred for 30 minutes. The turbid mixture turned clear with a white precipitate. The precipitated diazine by-product was filtered and washed with diethyl ether (60 ml). The combined ether filtrate was re-cooled to 0 °C and 2M HCl in ether (31.5 ml, 63 mmol, 1.5 equiv.) was added over 3 minutes. The flask was stirred at 0 °C for an additional 30 minutes. The mixture was filtered, and the white solid was collected and dried to give the desired O-cyclopropyl hydroxylamine hydrochloride salt 17a as a white solid.
For the synthesis of 17b the same procedure was followed. Once the precipitated diazine by-product was removed, the filtrate was concentrated and yielded the desired O-((1R,2R)-2-butylcyclopropyl)hydroxylamine product 17b as a colorless oil. To furnish O-cyclopropyl hydroxamates 18a-e, N-protection of 17a and 17b was accomplished utilizing standard literature reported conditions. Further experimental details for the N-protection procedures can be found in the supplementary information.
General Procedure for the Preparation of N-arylated-O-cyclopropyl Hydroxamates
In an oven-dried 8 mL vial, O-cyclopropyl hydroxamate (18a-e) (0.3 mmol, 1.0 equiv.) and cesium carbonate (196mg, 0.6 mmol, 2.0 equiv.) were suspended in dry toluene (1.5 mL, 0.1 M). The desired diaryliodonium salt (0.45 mmol, 1.5 equiv.) was added at room temperature in one portion. The mixture was stirred for 5–24 hours at room temperature, until TLC indicated complete consumption of the O-cyclopropyl hydroxamate starting material. Upon reaction completion, the mixture was filtered through celite. The celite was washed four times with ethyl acetate (5 ml each), the filtrate was collected, and the solvent was removed in vacuo. The crude product was purified using flash chromatography (10% EA in hexanes) on a Biotage Isolera system to give the desired N-arylated-O-cylcopropyl hydroxamate products (19a-s).
General Procedure for the Preparation of 2-Hydroxy-tetrahydroquinolines via [3,3]-Rearrangement
N-arylated-O-cyclopropyl hydroxamate (19a-s, 50 mg, 0.2 mmol, 1.0 equiv.) was added to an 8 mL oven-dried vial equipped with a stir bar. The vial was capped, placed under an argon atmosphere and trifluoroethanol (2.0 mL, 0.1M) was added. Triethylamine (55.8 μL, 0.4 mmol, 2.0 equiv.) was then added to the solution via syringe. The reaction mixture was stirred at rt for 6–24 hours. After complete consumption of the starting material was confirmed via TLC, the reaction mixture was concentrated under reduced pressure. The crude mixture was then purified using flash chromatography (12 % EA in hexanes) on a Biotage Isolera system to give the desired tetrahydroquinoline products (20a-s).
Tetrahydroquinoline 20a was further functionalized at the 2-position to furnish products 21-24 via modified literature procedures. Further experimental details for these procedures can be found in the supplementary information.
Supplementary Material
Acknowledgements
The authors would like to thank Dr. Byeong-Seon Kim for his preliminary work on this project as well as Ms. Zoe Punske for the preparation of the diaryliodonium salts. The authors are grateful for the financial Support received from Rice University, the National Institutes of Health (R01 GM-114609-04), the National Science Foundation (CAREER:SusChEM CHE-1546097), the Robert A. Welch Foundation (grant C-1764), Amgen (2014 Young Investigators’ Award for L.K.), Biotage (2015 Young Principal Investigator Award) and the National Science Foundation Graduate Research Fellowship (Grant No. 1842494, Award for K.L.). Additionally, the CN Yang Scholars program/funding from Nanyang Technological University (for Y.P.N.) is greatly appreciated.
Footnotes
Conflicts of interest
There are no conflicts to declare.
Electronic Supplementary Information (ESI) available: [Complete experimental procedures and characterization including 1H and 13C spectra are included]. See DOI: 10.1039/d0ob00611d
Notes and References
- 1.in Molecular rearrangements in organic synthesis (Ed.: Rojas CM), John Wiley & Sons, Inc., Hoboken, New Jersey, 2015, pp. 522–537. [Google Scholar]
- 2.Bartoli G, Palmieri G, Bosco M, Dalpozzo R, Tetrahedron Lett. 1989, 30, 2129–2132. [Google Scholar]
- 3.Cottrell TL, in The Strengths of Chemical Bonds, 2nd ed., Butterworths, London, 1958. [Google Scholar]
- 4.a) de Meijere A, Angew. Chem. Int. Ed. 1979, 18, 809–826 [Google Scholar]; b) Mills LR, Rousseaux SAL, Eur. J. Org. Chem. 2019, 8–26 [Google Scholar]; c) Wiberg KB, Acc. Chem. Res. 1996, 29, 229–234. [Google Scholar]
- 5.a) Gao HY, Ess DH, Yousufuddin M, Kürti L, J. Am. Chem. Soc. 2013, 135, 7086–7089 [DOI] [PubMed] [Google Scholar]; b) Gao HY, Xu QL, Keene C, Kürti L, Chem. Eur. J. 2014, 20, 8883–8887 [DOI] [PubMed] [Google Scholar]; c) Guo LR, Liu FT, Wang LY, Yuan HR, Feng L, Kürti L, Gao HY, Org. Lett. 2019, 21, 2894–2898 [DOI] [PubMed] [Google Scholar]; d) Patil AS, Mo DL, Wang HY, Mueller DS, Anderson LL, Angew. Chem. Int. Ed. 2012, 51, 7799–7803 [DOI] [PubMed] [Google Scholar]; e) Pecak WH, Son J, Burnstine AJ, Anderson LL, Org. Lett. 2014, 16, 3440–3443 [DOI] [PubMed] [Google Scholar]; f) Son J, Reidl TW, Kim KH, Wink DJ, Anderson LL, Angew. Chem. Int. Ed. 2018, 57, 6597–6600 [DOI] [PubMed] [Google Scholar]; g) Wang HY, Anderson LL, Org. Lett. 2013, 15, 3362–3365 [DOI] [PubMed] [Google Scholar]; h) Yuan HR, Guo LR, Liu FT, Miao ZC, Feng L, Gao HY, ACS Catal. 2019, 9, 3906–3912. [Google Scholar]
- 6.a) Hall DG, in Boronic acids : preparation and applications in organic synthesis, medicine and materials, Second ed., Wiley-VCH, Weinheim, 2011 [Google Scholar]; b) Langenhan JM Preparation and neoglycorandomization of digitoxin analogs as antitumor agents and ATPase inhibitors. U.S. Patent 20,090,075,842, March 19, 2009; c) Lei C, Shaoyu C, Feng F, Wenyuan L, Wei Q, Wenzcho S, Xinrui X Sterol derivative and its preparation method and application. Chinese Patent CN 106800580 A, June 6, 2017.
- 7.Yang D, Chang XW, Zhang DW, Jiang ZF, Song KS, Zhang YH, Zhu NY, Weng LH, Chen MQ, J. Org. Chem. 2010, 75, 4796–4805. [DOI] [PubMed] [Google Scholar]
- 8.Pearce AJ, Walter DS, Frampton CS, Gallagher T, J. Chem. Soc., Perkin Trans. 1 1998, 847–852. [Google Scholar]
- 9.a) Lorenz JC, Long J, Yang Z, Xue S, Xie Y, Shi Y, J. Org. Chem. 2004, 69, 327–334 [DOI] [PubMed] [Google Scholar]; b) Simmons HE, Smith RD, J. Am. Chem. Soc. 1958, 80, 5322–5324. [Google Scholar]
- 10.Wuts PGM, Greene TW, Greene TW, in Greene’s protective groups in organic synthesis, 4th ed., Wiley-Interscience, Hoboken, N.J., 2007, pp. 790–793. [Google Scholar]
- 11.a) Qiao JX, Lam PY, in Boronic Acids: Preparation and Applications in Organic Synthesis, Medicine and Materials Second ed. (Ed.: Hall DG), Wiley-VCH, Weinheim, 2011, pp. 315–361 [Google Scholar]; b) Ruiz-Castillo P, Buchwald SL, Chem. Rev. 2016, 116, 12564–12649. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.Yang Y, Wu XS, Han JW, Mao S, Qian XF, Wang LM, Eur. J. Org. Chem. 2014, 6854–6857. [Google Scholar]
- 13.a) Tinnis F, Stridfeldt E, Lundberg H, Adolfsson H, Olofsson B, Org. Lett. 2015, 17, 2688–2691 [DOI] [PubMed] [Google Scholar]; b) Merritt EA, Olofsson B, Angew. Chem. Int. Ed. 2009, 48, 9052–9070 [DOI] [PubMed] [Google Scholar]; c) Olofsson B, in Topics in Current Chemistry: Hypervalent Iodine Chemistry, (Ed.: Wirth T), Springer International Publishing, Switzerland, 2016, pp. 135–166. [Google Scholar]
- 14.Malmgren J, Santoro S, Jalalian N, Himo F, Olofsson B, Chem. Eur. J. 2013, 19, 10334–10342. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.a) Sakurai H, Pure & Appl. Chem. 1982, 54, 1–22 [Google Scholar]; b) Scott JD, Miller MW, Li SW, Lin SI, Vaccaro HA, Hong LW, Mullins DE, Guzzi M, Weinstein J, Hodgson RA, Varty GB, Stamford AW, Chan TY, McKittrick BA, Greenlee WJ, Priestley T, Parker EM, Bioorg. Med. Chem. Lett. 2009, 19, 6018–6022. [DOI] [PubMed] [Google Scholar]
- 16.Steemers L, Wijsman L, van Maarseveen JH, Adv. Synth. Catal. 2018, 360, 4241–4245. [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.